Roche Holding AG
SIX:ROG
Roche Holding AG
SIX:ROG
Price:
235.9 CHF
3.69%
Updated:
May 16, 2024
Roche Holding AG
Accounts Receivables
|
Roche Holding AG
Accounts Receivables Peer Comparison
Comparables:
NOVN
NLSP
S
SDZ
Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Roche Holding AG
SIX:ROG
|
Accounts Receivables
CHf11B
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
2%
|
|
|
Novartis AG
SIX:NOVN
|
Accounts Receivables
$7.8B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-3%
|
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Accounts Receivables
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Accounts Receivables
$2.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Roche Holding AG's Accounts Receivables?
Accounts Receivables
11B
CHF
11B
CHF
Based on the financial report for Dec 31, 2023, Roche Holding AG's Accounts Receivables amounts to 11B CHF.
What is Roche Holding AG's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
2%
2%
Over the last year, the Accounts Receivables growth was -5%. The average annual Accounts Receivables growth rates for Roche Holding AG have been 3% over the past three years , 2% over the past five years , and 2% over the past ten years .
You don't have any saved screeners yet
